Literature DB >> 3091262

Recombinant tumor necrosis factor: species specificity for a variety of human and murine transformed cell lines.

L Fransen, M R Ruysschaert, J Van der Heyden, W Fiers.   

Abstract

Tumor necrosis factor (TNF) exhibits cytotoxic or cytostatic activity on a wide range of animal and human transformed cell lines. Using pure, recombinant human and mouse TNF, we examined the degree of species specificity of the in vitro TNF activity on a variety of human and murine transformed cell lines. This species specificity was studied for the TNF activity alone or in synergism with IFN-gamma. Recombinant human and mouse TNF behave remarkably similarly regarding the in vitro cytolytic/cytostatic activity. However, a certain degree of species-specific preference could be revealed as human cell lines needed a higher concentration of recombinant mouse TNF than of recombinant human TNF to attain a similar effect, while on mouse cells the reverse was true. Also, synergism with IFN-gamma seemed more effective when the target cell was treated with homologous TNF.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3091262     DOI: 10.1016/0008-8749(86)90025-0

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  24 in total

1.  Interleukin-1 alpha inhibits the effects of gamma-interferon and tumor necrosis factor alpha on the expression of the major histocompatibility antigens by the rat endothelium.

Authors:  D Leszczynski
Journal:  Am J Pathol       Date:  1990-01       Impact factor: 4.307

2.  A randomised phase II study of carmustine alone or in combination with tumour necrosis factor in patients with advanced melanoma.

Authors:  A L Jones; M E O'Brien; A Lorentzos; C Viner; A Hanrahan; J Moore; J L Millar; M E Gore
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

3.  Lyophilized formulations of recombinant tumor necrosis factor.

Authors:  M S Hora; R K Rana; F W Smith
Journal:  Pharm Res       Date:  1992-01       Impact factor: 4.200

4.  Stable Escherichia coli-Clostridium acetobutylicum shuttle vector for secretion of murine tumor necrosis factor alpha.

Authors:  J Theys; S Nuyts; W Landuyt; L Van Mellaert; C Dillen; M Böhringer; P Dürre; P Lambin; J Anné
Journal:  Appl Environ Microbiol       Date:  1999-10       Impact factor: 4.792

5.  Species-specific TNF induction of thymocyte proliferation.

Authors:  M J Ehrke; R L Ho; K Hori
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

6.  Synergic action between tumor necrosis factor and endotoxins or poly(A.U) on cultured bovine endothelial cells.

Authors:  P A van de Wiel; R H Pieters; A van der Pijl; N Bloksma
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

Review 7.  Cytokine regulation of tight junctions.

Authors:  Christopher T Capaldo; Asma Nusrat
Journal:  Biochim Biophys Acta       Date:  2008-10-08

8.  Ectopic HOXB4 overcomes the inhibitory effect of tumor necrosis factor-{alpha} on Fanconi anemia hematopoietic stem and progenitor cells.

Authors:  Michael D Milsom; Bernhard Schiedlmeier; Jeff Bailey; Mi-Ok Kim; Dandan Li; Michael Jansen; Abdullah Mahmood Ali; Michelle Kirby; Christopher Baum; Leslie J Fairbairn; David A Williams
Journal:  Blood       Date:  2009-03-06       Impact factor: 22.113

9.  Differential sensitivity of renal cell carcinoma xenografts towards therapy with interferon-alpha, interferon-gamma, tumor necrosis factor and their combinations.

Authors:  A J Beniers; R J van Moorselaar; W P Peelen; F M Debruyne; J A Schalken
Journal:  Urol Res       Date:  1991

10.  Species specificity and involvement of other cytokines in endotoxic shock action of recombinant tumour necrosis factor in mice.

Authors:  P G Brouckaert; B Everaerdt; C Libert; N Takahashi; W Fiers
Journal:  Agents Actions       Date:  1989-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.